(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-(((1R,2R,3S,4S,5S)-2,3,4-trihydroxy-5-(((1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl)amino)cyclohexyl)methoxy)tetrahydro-2H-pyran-3,4,5-triol; 1,5,6-Trideoxy-5-[(?-D-glucopyranosyloxy)methyl]-1-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl]amino]-D-chiro-inositol
Validamycin D is a fully characterized chemical compound used as a reference standard of API Validamycin. The standard offered is compliant with regulatory guidelines. Validamycin D is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 12650-67-8
